Organization: Ontario Psychiatric Association
CME Accreditation: Section 1, Section 3, RCPSC Maintenance of Certification program
Date: Tuesday, June 7, 2022
Time: 7:30 pm - 9:00 pm ET
Location: Virtual Event
This event will be recorded, and the recording will be available to the registrants following the event for 14 days after its distribution to registrants.
Accreditation Information
This program is an accredited group learning activity (SECTION 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Psychiatric Association (CPA). The specific opinions and content of this event are not necessarily those of the CPA and are the responsibility of the organizer(s) alone.
This program is also an accredited self-assessment program (SECTION 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada and was approved by the Canadian Psychiatric Association. You may claim a maximum of 1.5 hours (credits are automatically calculated).
Viewing of event video recordings (without attending live) may be documented as a Section 2 Self-Learning credits.
Topic: Personal Reflections on Disparities in Indigenous Health and Mental Health
Speaker: Dr. Anna Banerji
In this presentation, Dr. Banerji will describe her experience with RSV in Inuit babies, her experience with her son and other observations as examples of a larger problem: lack of understanding of the impact of colonization on the physical and mental health of Indigenous peoples. She will include a broad overview of historical and present-day barriers faced by Indigenous persons, including biases and discrimination. She challenges physicians to do more for Indigenous populations.
About the Speaker
Dr. Anna Banerji has spent almost 30 years working with Indigenous populations. She has travelled to numerous Indigenous communities across Canada in various capacities and has been to the Arctic over 50 times. Her studies on respiratory syncytial virus (RSV) in Inuit babies have demonstrated that they have the highest rates of admission in the world with RSV lung infection bronchiolitis. In 2001, palivizumab, an antibody treatment, became licensed in Canada for the prevention of RSV. Dr. Banerji’s studies have shown that the cost of giving palivizumab to term Inuit infants is cheaper than the cost of admission and would prevent admission and excess suffering; however, this option has not been implemented yet. In 2004, she adopted her Inuk son, Nathan. When his mental health was deteriorating, there was a systemic failure to recognize his intergenerational trauma.
